Evidence map›Paper›PMID 20810541›Full record

ArticleToxicological sciences : an official journal of the Society of Toxicology2010

The role of CaMKII in calcium-activated death pathways in bone marrow B cells.

Stephanie L Bissonnette, Amelia Haas, Koren K Mann, Jennifer J Schlezinger

Abstract read
In one paragraph

Article in Toxicological sciences : an official journal of the Society of Toxicology, 2010. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Review
  2. Review
  3. From the Cover: Tributyltin Alters the Bone Marrow Microenvironment and Suppresses B Cell Development.Toxicological sciences : an official journal of the Society of Toxicology · 2017
    Article
  4. Article
  5. Article
  6. CaMKII in cerebral ischemia.Acta pharmacologica Sinica · 2011
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Stephanie L BissonnetteDepartment of Environmental Health, Boston University School of Public Health, Boston, Massachusetts 02118, USA.
Amelia Haas
Koren K Mann
Jennifer J Schlezinger

Funding

Training CoreP42ES007381 · NIEHS · BOSTON UNIVERSITY MEDICAL CAMPUS · PI HAHN, MARK E · 1995 to 2019
$46.1M
NIEHS NIH HHS P42 ES007381
6 · The paper itself

Abstract

Calcium is an essential signaling molecule in developing B cells, thus altering calcium dynamics represents a potential target for toxicant effects. GW7845, a tyrosine analog and potent peroxisome proliferator-activated receptor γ agonist, induces rapid mitogen-activated protein kinase (MAPK)-dependent apoptosis in bone marrow B cells. Changes in calcium dynamics are capable of mediating rapid initiation of cell death; therefore, we investigated the contribution of calcium to GW7845-induced apoptosis. Treatment of a nontransformed murine pro/pre-B cell line (BU-11) with GW7845 (40 μM) resulted in intracellular calcium release. Multiple features of GW7845-induced cell death were suppressed by the calcium chelator BAPTA, including MAPK activation, loss of mitochondrial membrane potential, cytochrome c release, caspase-3 activation, and DNA fragmentation. A likely mechanism for the calcium-mediated effects is activation of CaMKII, a calcium-dependent MAP4K. We observed that three CaMKII isoforms (β, γ, and δ) are expressed in lymphoid tissues and bone marrow B cells. Treatment with GW7845 increased CaMKII activity. All features of GW7845-induced cell death, except loss of mitochondrial membrane potential, were suppressed by CaMKII inhibitors (KN93 and AIP-II), suggesting the activation of multiple calcium-driven pathways. To determine if CaMKII activation is a common feature of early B cell death following perturbation of Ca(2+) flux, we dissected tributyltin (TBT)-induced death signaling. High-dose TBT (1 μM) is known to activate calcium-dependent death. TBT induced rapid apoptosis that was associated with intracellular calcium release, CaMKII activation and MAPK activation, and was inhibited by AIP-II. Thus, we show that early B cells are susceptible to calcium-triggered cell death through a CaMKII/MAPK-dependent pathway.

Indexed as

AnimalsApoptosisB-LymphocytesBone Marrow CellsCalciumCalcium-Calmodulin-Dependent Protein Kinase Type 2Calcium SignalingCell LineChelating AgentsEgtazic AcidEnzyme ActivationEnzyme InhibitorsIsoenzymesLigandsMAP Kinase Kinase 4Membrane Potential, Mitochondrial1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acidCalciumCalcium-Calmodulin-Dependent Protein Kinase Type 2Chelating AgentsEgtazic AcidEnzyme InhibitorsGW 7845IsoenzymesLigandsMAP Kinase Kinase 4OxazolesTrialkyltin CompoundstributyltinTyrosine

Identifiers

PMID20810541
PMCPMC2955217

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.